08/01/2009 (Agence Europe) - On Thursday 8 January, the European Commission gave clearance for the proposed concentration whereby Teijin Pharma Limited (“Teijin Pharma”, Japan), belonging to Teijin Limited (“Teijin”, Japan), and Laboratories del Dr Esteve S.A. '”Esteve”, Spain) plan to acquire joint control of Oximeplus S.A. (Spain), currently controlled by Esteve, by way of purchase of shares. The activities of the companies considered are: - Teijin Pharma: solutions for both...